A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

Aria ePrescribing v13.6 MR1.2 user training guide

Description
Aria E-Prescribing v13.6 MR1.2 User Training Guide Every effort has been made to ensure that the material in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/Aria-ePrescribing-v13.6-MR1.2-user-training-guide.pdf

CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-VINCRISTINE (21) (CHOP 21) Regimen Lymphoma – CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Indication Non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CHOP21-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine-21-Ver-1.2.pdf

CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-ETOPOSIDE-PREDNISOLONE-VINCRISTINE Regimen (CEOP) Lymphoma – CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine Indication Non-Hodgkin’s Lymphoma where
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine-Ver-1.2.pdf

Bendamustine

Description
Chemotherapy Protocol LYMPHOMA BENDAMUSTINE There are multiple versions of this protocol in use. Please ensure you have the correct protocol for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine.pdf

InP DoxorubicinIfosfamideVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-IFOSFAMIDE In-Patient Regimen Regimen Sarcoma – InP-Doxorubicin - Ifosfamide Indication Soft tissue sarcoma WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinIfosfamideVer1.pdf

Ruxolitinib

Description
Chemotherapy Protocol Myelofibrosis Ruxolitinib Regimen • Myelofibrosis – Ruxolitinib Indication • Ruxolitinib is recommended as an option for treating disease-related splenomegaly or symptoms
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myelofibrosis/Ruxolitinib.pdf

CH003 SOP regimen validation full

Description
Standard Operating Procedure Validation of Chemotherapy Protocols in ARIA (Wessex) (SOP:CH003) 1. Objective 1.1 The purpose of this standard
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003-SOP-regimen-validation-full.pdf

CH003 regimen validation checklist ver2.0x

Description
Central South Coast Cancer Network Strength through Partnership Checklist for Verification of Treatment Regimens in ARIA Version 10 Regimen’s Name
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003regimenvalidationchecklistver20x.pdf

Fulvestrant-Palbociclib

Description
Chemotherapy Protocol Breast Cancer Fulvestrant-Palbociclib Regimen • Breast Cancer – Fulvestrant-Palbociclib Indication Palbociclib with fulvestrant is recommended for use within the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Fulvestrant-Palbociclib.pdf

Pertuzumab/Trastuzumab SC

Description
Chemotherapy Protocol BREAST CANCER Regimen Pertuzumab / Trastuzumab SC • Breast Cancer – Trastuzumab / Pertuzumab SC Indication • Treatment of early breast cancer (EBC) in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/PertuzumabTrastuzumab-SC.pdf
321 to 330 of 1000
Previous … 31 32 33 34 35 … Next